The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
After more than three decades at Wilson Sonsini, Ian Edvalson explains why he moved to expand his life sciences transactional practice
The firm says new additions position Brown Rudnick as a market leader in tech, life sciences, and global litigation
Amongst a sea of mergers, Lathrop GPM and HG Law have set out plans to combine, positioning themselves to compete with both IP boutiques and full-service firms
Labelled the ‘largest law firm merger in history’, the new outfit could also spell an opportunity for US clients to capitalise on Hogan Lovells' UPC expertise
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Jin Ooi, who joins as a partner today, said he is excited to offer a ‘rounded’ IP service as the firm deepens its litigation expertise in the UK and Europe
As generics celebrate, practitioners believe innovator companies should brace for an ‘uphill battle’ when trying to prove induced infringement
Sponsored
Sponsored
-
Sponsored by IPSILONJoran Michiels of IPSILON Belgium examines how recent EPO and UPC decisions may support inventive-step arguments for CARs, ADCs, bispecific antibodies, and other next-generation therapeutics -
Sponsored by Licks AttorneysSenior legal practitioners of Licks Attorneys explain how antibody characterisation during prosecution can shape patent scope, validity, and enforcement in Brazil, with lessons from the US Amgen v Sanofi decision
-
Sponsored by Liu Shen & AssociatesKe Mou and Stephen Zou of Liu Shen & Associates outline China’s evolving framework on pharmaceutical intellectual property protection, examining how data exclusivity, patent term extension, patent linkage, and enforcement mechanisms support innovation
Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future
Pedro Moreira outlines proposals by INPI that look set to open a discussion regarding biological materials, extracts, sequences, genetically edited plants, and computer programs
Firm says its work with a nonprofit client could signal a sea change in how - and when - law firms enter the drug development process
Sofie McPherson says she is excited to work at a firm that offers an integrated approach between attorneys and litigators
Interviews; Exclusives
Interviews; Exclusives
Natasha Daughtrey shares how firms can help their women litigators take the lead on trials, and why she is seeing a convergence of tech and life sciences disputes
Mathew Lucas has joined Pearce IP after spending more than 25 years at Qantm IP-owned firm Davies Collison Cave
Managing partner Mark O’Donnell explains why people are at the centre of the Australian outfit’s investment focus and how being independent benefits the firm
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
In an exclusive interview, Rouse CEO Luke Minford, Arnold & Siedsma managing partner Steve Duxbury, and Wrays executive chairman Gary Cox discuss plans to build the world’s first ‘truly integrated’ global IP services business
The firm has added six practitioners in recent weeks as it takes measured steps to build its IP practice with a focus on trade secrets work
-
Weekly take: Why ‘impossible to ignore’ IP became my 'Jedi path'
Shaina Haria, a final-seat trainee at an international law firm’s UK office, shares how she fell in love with IP and why the area of law has changed the way she views the world -
Weekly take: Why the EU must press ahead with unitary SPCs
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer -
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone
Former professional cricketer Ben Scott talks through the challenges of building a legal tech platform, transitioning from sportsman to entrepreneur and why he believes he has found a gap in the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Chris Adams, Managing IP’s research lead, joins us to explain what practitioners need to know ahead of our first rankings release of 2026
Michelle Lee discusses reaching milestones at the USPTO, AI’s role in legal work, and how to empower women in tech and IP
João Negrão, EUIPO executive director, is joined by a seasoned official to reflect on three decades of stories
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
In our latest podcast, Deborah Hampton talks through her hopes for the year, INTA’s patent focus, London 2026, and her love of music
In the final episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss the IP Inclusive Charter and the senior leaders’ pledge
In the ninth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP & ME, a community focused on ethnic minority IP professionals
In the eighth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Ability, a network for disabled people and carers active in the IP profession
The shortlist for our annual Americas Awards will be published next month, with potential winners in more than 90 categories set to be revealed
The LMG Life Sciences Awards announces the 2025 winners for the 13th annual awards!
Practitioners and law firms should keep their eyes peeled as the shortlist for our annual Awards is set to be released